Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Carlo Visco | Researchclopedia

Back to researchers

Carlo Visco

University of Verona ORCID

439

Works

10,688

Citations

54

h-index

151

i10-index

Research Topics

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Viral-associated cancers and disorders

Affiliations

University of Insubria2016–2016

University of Verona2002–2025

Cleveland Clinic2014–2014

Hudson Institute2017–2017

Memorial Sloan Kettering Cancer Center2014–2014

Top Works

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Tina Green,Ken H. Young,et al.

2012680 citations

CAR-T cell therapy research

Monoclonal and Polyclonal Antibodies Research

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Shimin Hu,Zijun Y. Xu‐Monette,et al.

2013672 citations

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti,Chiara Cattaneo,et al.

2020551 citations

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Zijun Y. Xu‐Monette,Lin Wu,et al.

2012383 citations

The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

Davide Rossi,Valeria Spina,et al.

2011376 citations

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Carlo Visco,Y Li,et al.

2012357 citations

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Shimin Hu,Zijun Y. Xu‐Monette,et al.

2013246 citations

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Davide Rossi,Lodovico Terzi-di-Bergamo,et al.

2015214 citations

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Ziju Y. Xu-Monette,Min Xiao,et al.

2019177 citations